Emerald Mutual Fund Advisers Trust’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-223,213
| Closed | -$4.5M | – | 241 |
|
|
2021
Q3 | $4.5M | Sell |
223,213
-238,633
| -52% | -$6.59M | 0.16% | 129 |
|
|
2021
Q2 | $17.2M | Sell |
461,846
-2,412
| -0.5% | -$73.9K | 0.56% | 74 |
|
|
2021
Q1 | $11.9M | Buy |
464,258
+2,300
| +0.5% | +$58.7K | 0.39% | 97 |
|
|
2020
Q4 | $10.2M | Buy |
461,958
+110,089
| +31% | +$2.42M | 0.35% | 102 |
|
|
2020
Q3 | $6.33M | Buy |
351,869
+4,458
| +1% | +$92.3K | 0.28% | 94 |
|
|
2020
Q2 | $8.82M | Sell |
347,411
-134,590
| -28% | -$2.9M | 0.42% | 84 |
|
|
2020
Q1 | $8.85M | Sell |
482,001
-179,051
| -27% | -$3.48M | 0.56% | 64 |
|
|
2019
Q4 | $14.6M | Sell |
661,052
-117,464
| -15% | -$2.36M | 0.59% | 65 |
|
|
2019
Q3 | $11.2M | Sell |
778,516
-65,379
| -8% | -$935K | 0.49% | 74 |
|
|
2019
Q2 | $13.3M | Sell |
843,895
-47,593
| -5% | -$647K | 0.53% | 72 |
|
|
2019
Q1 | $13.1M | Sell |
891,488
-11,951
| -1% | -$137K | 0.52% | 62 |
|
|
2018
Q4 | $9.66M | Sell |
903,439
-5,781
| -0.6% | -$76K | 0.45% | 83 |
|
|
2018
Q3 | $13.9M | Buy |
909,220
+382,361
| +73% | +$5.57M | 0.47% | 84 |
|
|
2018
Q2 | $6.45M | Buy |
526,859
+375,288
| +248% | +$4.71M | 0.23% | 141 |
|
|
2018
Q1 | $1.45M | Sell |
151,571
-419,290
| -73% | -$4.52M | 0.06% | 209 |
|
|
2017
Q4 | $5.16M | Buy |
+570,861
| New | +$4.2M | 0.2% | 147 |
|
|
2015
Q3 | – | Sell |
-125,000
| Closed | -$1.74M | – | 289 |
|
|
2015
Q2 | $1.74M | Buy |
125,000
+70,416
| +129% | +$1.29M | 0.13% | 144 |
|
|
2015
Q1 | $1.21M | Buy |
54,584
+24,094
| +79% | +$542K | 0.1% | 157 |
|
|
2014
Q4 | $502K | Buy |
+30,490
| New | +$352K | 0.04% | 186 |
|
Other funds holding DRNA
Emerald Mutual Fund Advisers Trust's DRNA Position: Q4 2021 in Review
Emerald Mutual Fund Advisers Trust sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 223,213 shares — an estimated $4.5M sold.
Emerald Mutual Fund Advisers Trust first reported a position in DRNA in Q4 2014 and held it in 19 quarters. The position peaked at $17.2M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Emerald Mutual Fund Advisers Trust reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Emerald Mutual Fund Advisers Trust sold 223,213 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $4.5M.
- Emerald Mutual Fund Advisers Trust first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2014 and held it in 19 quarters.
- Emerald Mutual Fund Advisers Trust's Dicerna Pharmaceuticals, Inc. position peaked at $17.2M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2021, filed 2 Feb 2022.